Status:
COMPLETED
PegIntron Injection Surveillance Plan (Study P04123)
Lead Sponsor:
Merck Sharp & Dohme LLC
Conditions:
Hepatitis C, Chronic
Eligibility:
All Genders
Brief Summary
Surveillance will be conducted at digestive departments of internal medicine in university or general hospitals where participants with chronic hepatitis C are generally treated. The purpose of this s...
Detailed Description
The investigator will record continuously from the first patient since the day of contract to the numbers of patients of contract based on Pegintron approval.
Eligibility Criteria
Inclusion
- Participants with chronic hepatitis C treated with peginterferon alfa-2b.
- Signed written contract.
Exclusion
- None
Key Trial Info
Start Date :
June 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 1 2009
Estimated Enrollment :
1267 Patients enrolled
Trial Details
Trial ID
NCT00723931
Start Date
June 1 2006
End Date
November 1 2009
Last Update
November 4 2015
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.